Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
After a year of soul searching and strategic review, GE announced its move today to spin off GE Healthcare into a standalone company over the next 12 to 18 months. The goal, the company said, is a leaner corporate structure with substantial reductions in debt.
A wireless device was comparable to cardiac MRI in accuracy when detecting heart dysfunction in childhood cancer survivors who were treated with anthracycline chemotherapy, according to a study published in Clinical Cancer Research.
Researchers from Mayo Clinic have developed a method analyzing blood sugar levels to predict pancreatic cancer up to three years before diagnosis, according to a study published in Gastroenterology.
Researchers from MedStar Health have been awarded an 18-month federal contract to support the development and testing of digital tools for the collection of patient-reported outcome data.
The combination of wearable monitoring with predictive analytics could hasten identifying acute exacerbation in patients with chronic obstructive pulmonary disease (COPD), according to a study published in JMIR mHealth and uHealth.
Over half of infection preventionists (IPs) reported a lack of technology as the main barrier in preventing healthcare-associated infections (HAI), according to a survey commissioned by 3M.
